The largest database of trusted experimental protocols

Poly lactic co glycolic acid

Manufactured by Merck Group
Sourced in United States, India, Germany

Poly(lactic-co-glycolic acid) is a biodegradable and biocompatible polymer used in various laboratory applications. It is a copolymer of lactic acid and glycolic acid, with adjustable properties depending on the ratio of the two monomers. The polymer is commonly employed in the development and formulation of controlled-release systems, drug delivery devices, and tissue engineering scaffolds.

Automatically generated - may contain errors

21 protocols using poly lactic co glycolic acid

1

Anticancer Effects of Copper Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HCC cell lines Huh7 and PLC/PRF/5 were purchased from ATCC (Middlesex, UK). DS, 5-fluorouracil (5-FU), copper chloride (CuCl2), copper gluconate (CuGlu), poly lactic-co-glycolic acid (PLGA), poly(vinyl acetate), cyanomethyl diphenylcarbamodithioate (PVA), dichloromethane, poly-2-hydroxyethyl methacrylate (poly-HEMA) and bovine serum albumin (BSA) were purchased from Sigma (Dorset, UK). DMEM and fetal calf serum (FCS) were supplied by Lonza (Wokingham, UK). Ki-67 and BAX antibodies were purchased from Cell Signaling (Danvers, MA, USA). NFkBp65 and ALDH1 antibodies were from Abcam. Sorafenib was from BioVision (CA, USA). Cell culture inserts were purchased from Fisher (Loughborough, UK). Lipo-DS was provided by Prof. Xing Tang (Shenyang Pharmaceutical University, China).
+ Open protocol
+ Expand
2

Ovalbumin-loaded Microsphere Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
OVA-microspheres were prepared using a homogenization/ solvent evaporation method, as described previously (21 (link)), with 400 µl of OVA-containing water (50 mg OVA/ ml) and 2 ml of ethyl acetate containing poly(lactic-coglycolic acid) (100 mg/ml, Sigma-Aldrich). Fluorescent microspheres were prepared by adding FITC (5 µg/ml) to the ethyl acetate phase.
+ Open protocol
+ Expand
3

PLGA Microspheres for Ovalbumin Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microspheres containing OVA (OVA-microspheres) were prepared using a homogenization/solvent evaporation method described previously [53 (link)]. Briefly, 400 ml of 50 mg/ml OVA in water was mixed with 2 ml of 100 mg/ml poly(lactic-co-glycolic acid) in ethyl acetate (Sigma-Aldrich). The OVA content was determined using the Micro Bicinchoninic Acid assay kit (Pierce, Rockford, IL, USA) after lysing the microspheres in lysis buffer (0.1 % SDS and 0.1 N NaOH). Fluorescence-labeled microspheres were prepared by adding FITC (5 mg/ml) to the ethyl acetate phase.
+ Open protocol
+ Expand
4

Microneedle-Mediated Transdermal Insulin Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
These chemicals were procured from Sigma-Aldrich and used without additional purification: poly(vinyl alcohol) (98–99% hydrolyzed, MW: 31,000–50,000), polyethyleneimine (PEI, 50% [w/v] in water, analytical standard), dichloromethane (DCM, MW: 84.93 g/mol, anhydrous, ≥99.8%, mp: −97 °C, ρ: 1.325 g/mL), poly(lactic-co-glycolic acid) (PLGA, MW: 40,000–75,000, lactide: glycolide = 65:35), glucose oxidase (GOx), fluorescein isothiocyanate (FITC)-labeled insulin (insulin-FITC labeled human), insulin (human recombinant, insulin), hydrochloric acid (HCl), sodium hydroxide (NaOH), phosphate-buffered saline (PBS), streptozotocin (STZ), citric acid and sodium citrate dihydrate. U-BioMed Inc (Daegu, Korea) provided the stainless steel MNs, poly (methyl methacrylate) (PMMA) and sodium bicarbonate (NaHCO3) were obtained from a local market. All Sprague Dawley (SD) rats were acquired from Orient Bio Inc. (Seoul, Korea).
+ Open protocol
+ Expand
5

Murine Cytokine and Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biotin-labelled sheep anti-mouse IgE antibody (cat. no. 1110-08) was purchased from Southern Biotech. HRP-labelled sheep anti-mouse IgG1 antibody (cat. no. A10551) and HRP-labelled sheep anti-mouse IgG2a antibody (cat. no. A10685) was purchased from Life Technologies; Thermo Fisher Scientific, Inc. HRP-labelled streptavidin (cat. no. A0303) was obtained from Beyotime Institute of Biotechnology. Mouse IL-4, IL-10, IL-13, TNF-α, IFN-γ and TGF-β ELISA Kits were purchased from R&D Systems. Cholera toxin and poly (lactic-co-glycolic acid) were purchased from SigmaAldrich; Merck KGaA. APC rat anti-mouse CD4 antibody (cat. no. 553051), FITC rat anti-mouse CD25 antibody (cat. no. 558689) and PE rat anti-mouse Foxp3 (cat. no. 560408) were obtained from BD Pharmingen; BD Biosciences. Anti-A20 antibody (product code ab74037) was purchased from Abcam, and anti-p65 antibody (product no. 3033S) and anti-β-actin antibody (4967S) were obtained from Cell Signaling Technology. The 293T cell line (CBP60439) was obtained from Cobioer.
+ Open protocol
+ Expand
6

Optofluidic Brain Implant Procedure

Check if the same lab product or an alternative is used in the 5 most similar protocols
The optofluidic devices were implanted into the brain of adult mice following a similar method used for our previous soft neural implants.[25 (link)] Animals were mounted into a stereotaxic apparatus and anesthetized using isoflurane, while they rested on a heating pad for the duration of the procedure. After securing its head onto the apparatus, the mouse’s skull was exposed via a superficial midline incision performed under aseptic conditions. Following the identification of the desired stereotaxic coordinates for the implantation of the device, it was proceeded to drill a small opening for placement of the optofluidic probe. The soft RF harvester was implanted under the skin, caudal to the injection site. Placement of the optofluidic probe into the brain cortex was performed using a stereotaxic holder adapted for these devices, following temporary stiffening of the implant with a biodegradable polymer (poly(lactic-co-glycolic acid); Sigma-Aldrich Inc.). After the implant was secured, the mouse’s skin was sutured and the animal was set aside for recovery. The step-by-step process of the surgery can be found in Figure S9 in the Supporting Information. This same method can be referenced in Park et al.[25 (link)]
+ Open protocol
+ Expand
7

Synthesis and Characterization of Polymeric Materials

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly(lactic-co-glycolic acid) (ratio 50:50; Mw 7–17 kDa; alkyl ester terminated), polystyrene (Mw 35 kDa), fluorescein (acid free, 95%), Nile blue chloride (85%), Nile red (technical grade), IR780 (98%), fluorescein diacetate (FDA), dextran (9–11 kDa), acrylamide (molecular biology grade), and N,N′-methylene bis(acrylamide) (99%) were purchased from Sigma-Aldrich. Pluronic F127 (13 kDa) was purchased from O-BASF. Lithium acylphosphinate salt was synthesized according to a procedure published by Fairbanks et al.63 (link) Dextran was acetalated according to a procedure described by Suarez et al.64 (link) The synthesis of polyesters 1 and 2 can be found elsewhere.45 (link) Chloroform (CHCl3, 99.8%, EMD), dimethylformamide (DMF, 99%, Aldrich), tetrahydrofuran (THF, 99%, Fischer Scientific), and deuterated water (D 99.9%, Cambridge Isotope Inc.) were used without further purification. Deionized water (DI H2O) was purified from a Millipore system (18.2 MΩ).
+ Open protocol
+ Expand
8

Curcumin-Loaded PLGA-PEG Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly(lactic-co-glycolic acid) (50:50, Carboxy-terminated, MW 38,000–54,000 Da) was purchased from Sigma Aldrich (St. Louis, MO, USA). 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[Carboxy(Polyethylene Glycol)-2000] (DSPE-PEG) were obtained from Avanti Polar Lipids (Alabaster, Alabama). Curcumin (95% total Curcuminoid content) was purchased from Alfa Aesar. Chloroform, Acetonitrile and other solvents were obtained from Sigma Aldrich.
+ Open protocol
+ Expand
9

Multifunctional Nanoparticle Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Iron(II) chloride, iron(III) chloride, oleic acid, sodium hydroxide, chlorhydric acid, 4,6-diamidino-2-phenylindole (DAPI), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT), polyvinylalcohol (PVA, MW = 30–70 kDa), poly(lacticco-glycolic acid) (PLGA, molar ratio of 50:50, MW = 7000–17,000), N-hydroxysuccinimide (NHS), dicyclohexyl carbodiimide (DCC), dichloromethane (DCM), dimethyl sulfoxide (DMSO), and folic acid were purchased from Sigma-Aldrich. Poly(ethylene glycol amine) (PEG-diamine, MW 3400) was received from Laysan Bio, Inc., Doxorubicin (DOX) was bought from Beijing HuaFeng United Technology Co., Ltd. Cell culture medium [Dulbecco’s modified Eagle’s medium (DMEM)], penicillin, streptomycin, and fetal bovine serum (FBS) were obtained from Gibco BRL (Annapolis, MD, United States). All chemicals were of analytical grade and used without further purification, and all aqueous solutions were prepared using ultrapure water from a Milli-Q system (Millipore, Billerica, MA, United States).
+ Open protocol
+ Expand
10

Smart Radiotherapy Biomaterials for CBD Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Smart radiotherapy biomaterials (SRBs) were prepared as described in previous work (14 (link)) using 200 mg of poly(lactic-co-glycolic) acid (Sigma-Aldrich) with MW 40,000–75,000 dissolved in 4 mL of Acetone. The resulting blend was loaded with a constant flow rate into a silicon tubing (VWR and Versilic) using a Harvard apparatus (Harvard Bioscience) and dried at 50°C for 72 h. The dried biomaterials were cut into 4 mm length to incorporate the CBD payload. CBD payloads were custom loaded into the SRBs with a unique potential for image-guided RT and sustained in situ delivery of the CBD payload. The SRBs are customizable allowing for loading of different concentration of CBD payloads tagged with fluorescence dye and the incorporation of high-Z nanoparticles (NPs) for enhanced computed tomography (CT) imaging contrast.
In vitro release of payloads was investigated by placing CBD-loaded SRBs into wells of a microplate, triplicated for each day the payload release was observed. The fluorescence intensity of the released payload was read using a microplate reader/photometer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!